Cardiac muscle contractility pathways

“Cardiac muscle contractility pathways" refers to the diverse network of molecular signaling cascades that regulate the contraction strength and timing of heart muscle cells. These pathways coordinate the influx of calcium through voltage-gated calcium channels, the release of calcium from the sarcoplasmic reticulum (via ryanodine receptors), and the interaction of contractile proteins actin and myosin. Key molecular regulators include beta-adrenergic receptors (modulating cyclic AMP and protein kinase A activity), phospholamban/SERCA (regulating calcium reuptake), and troponin (regulating actin-myosin interaction). Many cardiovascular drugs act by modulating specific components of these pathways, ultimately influencing the force or rhythm of cardiac contraction[2][3][4][6]. Due to the pathway-level nature of this term, it is not a single drug target as conventionally defined.

Other names

Cardiac muscle contraction signaling pathwaysCardiac excitation-contraction coupling pathwaysCardiac contractility signaling cascadesMyocardial contractility pathways

Modulation of intracellular cyclic AMP/cGMP; Alteration of calcium influx/release from sarcoplasmic reticulum; Regulation of beta-adrenergic receptor signaling; Phosphorylation of contractile or regulatory proteins (e.g., troponin, phospholamban)